William Blair reaffirmed its positive stance on CyberArk Software (NASDAQ:CYBR), maintaining an Outperform rating. The firm's analyst, Jonathan Ho, provided insights into the company's growth and ...

Tilda Swinton brings the heat to a snowy scene, Tom Tykwer delivers an overlong opening night film and more from Day 2 of the Berlin Film Festival.

Airbnb said that nights booked by outbound Chinese tourists rose 25% in the fourth quarter. It also saw a 30% growth in ...

In a report released today, Sami Corwin from William Blair maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report). The ...

Equities research analysts at William Blair decreased their Q1 2025 earnings per share estimates for shares of AptarGroup in ...

Analysts at William Blair reduced their Q1 2025 earnings estimates for shares of Onsemi in a research report issued to clients and investors on Tuesday, February 11th. William Blair analyst J.

West Pharmaceutical reported Q4 earnings and revenue above expectations but issued a weak 2025 forecast. William Blair ...

National Museums Northern Ireland (NMNI) is to return further human remains to Hawaii. Human remains and other sacred objects ...

Edwards Lifesciences beat Q4 estimates with $1.39B in sales, driven by growth in TMTT, TAVR, and Surgical. The company ...